DeuterOncology
0754.971.388 · rovalta.com · 26/09/2026
ACTIVE
DeuterOncology
Financial year 2025 · Closed on 31/12/2025
Net result-3,6 M €-70,3 %over 1 year
Gross margin-3,3 M €-65,0 %over 1 year
Equity-2,6 M €-372,9 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBODeuterOncology is a Public limited company incorporated in 2020. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Liège.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0754.971.388
- Incorporation
- 28/09/2020
- Legal form
- Public limited company
- Registered office
- Clos Chanmurly 13
4000 Liège · WallonieSee on map - Contributed capital
- 8 598 171,15 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Financials
Source · NBB, 7 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -3,3 M € | -65.0% | -2 M € | -6.6% | -1,9 M € | +18.8% | -2,3 M € | -108% | -1,1 M € |
| EBITDA | -3,3 M € | -68.3% | -2 M € | -5.8% | -1,9 M € | +18.2% | -2,3 M € | -108% | -1,1 M € |
| Operating result | -3,3 M € | -46.2% | -2,3 M € | -2.1% | -2,2 M € | +2.3% | -2,3 M € | -108% | -1,1 M € |
| Net result | -3,6 M € | -70.3% | -2,1 M € | -4.2% | -2 M € | +15.0% | -2,4 M € | -117% | -1,1 M € |
| Balance sheet | |||||||||
| Equity | -2,6 M € | -373% | 965,5 k € | -43.4% | 1,7 M € | -48.4% | 3,3 M € | +9465% | -35,3 k € |
| Total assets | 688 k € | -45.9% | 1,3 M € | -35.7% | 2 M € | -45.2% | 3,6 M € | +513% | 587,8 k € |
| Cash | 210,7 k € | -74.6% | 829,1 k € | -46.6% | 1,6 M € | -56.3% | 3,6 M € | +567% | 532,2 k € |
| Debts | 3,3 M € | +992% | 304,4 k € | +13.2% | 269 k € | -8.4% | 293,7 k € | -52.9% | 623,1 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20255 active · 12 ended
Active mandates
Alexander Patrick Dolan
ActiveIker Huerga
ActiveKipp Richard Fairchild Davis
ActiveActive
Ended mandates
Other companies at this address
Clos Chanmurly 13 4000 Liège| Company | CBE no. |
|---|---|
1Spatial Belgium● Active | 0423.865.353 |
AASA Architectes● Active | 0422.476.471 |
AGENCE SOLA● Active | 0797.702.858 |
A LEE● Active | 0470.979.441 |
ANK HOME CARE● Active | 1031.481.964 |
ARTISAN CONSEIL HABITAT● Active | 0535.810.281 |
AVENIR ENERGIE● Active | 0787.201.817 |
B&B Investment Belgium● Active | 0461.754.543 |
B.C.D.E.M.● Active | 0800.169.628 |
| 0872.490.353 | |
| 0896.051.752 | |
ENERIX● Active | 1040.959.557 |
EQUIFIDES● Active | 0761.585.305 |
FBI● Bankrupt | 0459.149.203 |
Fondation Juliette● Active | 0726.524.951 |
General Immobilaria Company● Active | 0472.854.907 |
GESCOM● Liquidation | 0445.791.808 |
| 1025.279.112 | |
GRID ALTERNATIVE● Active | 1030.248.480 |
HAPPINESS FIT● Active | 0799.773.710 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 23/09/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 16 months |
| Filing date | 23/06/2026 | 27/06/2025 | 20/06/2024 | 06/12/2023 | 09/03/2023 |
| General meeting | 29/05/2026 | 10/06/2025 | 15/06/2024 | 01/12/2023 | 27/05/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/05/2026 | 23/06/2026 | French | |
| Abridged model | 31/12/2024 | 10/06/2025 | 27/06/2025 | French | |
| Abridged model | 31/12/2023 | 15/06/2024 | 20/06/2024 | French | |
| Micro modelCorrection | 31/12/2022 | 01/12/2023 | 06/12/2023 | French | |
| Micro model | 31/12/2022 | 29/06/2023 | 07/07/2023 | French | |
| Micro model | 31/12/2021 | 27/05/2022 | 09/03/2023 | French | |
| Micro model | 31/12/2021 | 27/05/2022 | 15/09/2022 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20255 active · 12 ended
Active mandates
Alexander Patrick Dolan
ActiveIker Huerga
ActiveKipp Richard Fairchild Davis
ActiveActive
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates12/05/2026DEMISSIONS, NOMINATIONS
- Mandates08/04/2026STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates22/07/2025DEMISSIONS, NOMINATIONS
- Capital / shares20/06/2024CAPITAL, ACTIONS
- Mandates26/09/2023DEMISSIONS, NOMINATIONS
- Capital / shares28/06/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates02/01/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Other09/08/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-3,6 M €↓
- 2024Annual accounts 2024-2,1 M €↓
- 2023Annual accounts 2023-2 M €↑
- 2022Annual accounts 2022-2,4 M €↓
- 2021Annual accounts 2021-1,1 M €
- 28/09/2020IncorporationPublic limited company